Last reviewed · How we verify

NCT06091904

Effects of Sufentanil on the Intraoperative Hemodynamics

Recruiting now NA Last updated 16 September 2025
What this trial tests

NA trial testing Sufentanil in Intraoperative Hypotension in 92 participants. Currently enrolling.

Timeline
24 November 2023
Primary endpoint
1 November 2025
1 November 2026

Quick facts

Lead sponsorSeoul National University Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment92
Start date24 November 2023
Primary completion1 November 2025
Estimated completion1 November 2026
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

19 and older, any sex, with Intraoperative Hypotension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a randomized, controlled trial. A total of 92 patients will be randomized to receive sufentanil or remifentanil during extracranial-intracranial bypass surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Sufentanil

Trials testing the same drug.

Other recruiting trials for Intraoperative Hypotension

Currently open trials in the same condition.

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06091904.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing